Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 1, 2001
Grant Date -
N/A
app pub date -
Oct 7, 1998
filing date -
Apr 18, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
Composition and methods for treating ocular allergic reactions are disclosed. In particular, the invention is directed to compounds which inhibit human conjunctival mast cell degranulation.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully